Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
![Essential](https://www.g2intelligence.com/wp-content/uploads/2023/11/Essential.png)
![62934_G2_Subscription Website Images_JL V1](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V1.png)
![Special-Report](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Report.png)
![62934_G2_Subscription Website Images_JL V12](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V12.png)
![Special-Analysis](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Analysis.png)
![Elite](https://www.g2intelligence.com/wp-content/uploads/2023/11/Elite.png)
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
![paper_magnifing_glass_512](https://www.g2intelligence.com/wp-content/uploads/2023/11/paper_magnifing_glass_512.png)
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
FDA Announces Informatics Community to Support Precision Medicine Initiative
By Kelly A. Briganti, Editorial Director, G2 Intelligence The U.S. Food and Drug Administration (FDA) has announced the development of precisionFDA, "an informatics community and supporting platform" to assist efforts to maximize the potential of genetic...
LabCorp Surpasses Quest as Largest Laboratory Company
By Ron Shinkman, Editor, Laboratory Industry Report With its second quarter earnings report, LabCorp has officially eclipsed Quest Diagnostics as the nation's largest laboratory company. LabCorp reported net income for the second quarter ending June 30 of $168.4...
AMP Offers Senate Committee Proposal for Regulation of Laboratory-Developed Tests
By Stephanie Murg, Managing Director, G2 Intelligence With the Food and Drug Administration poised to reverse its "enforcement discretion" and begin regulating laboratory-developed tests (LDTs) in the near future, industry groups are on the offensive. On August 4,...
Illumina Selects Second Round of Genomics Companies for Accelerator
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Illumina (San Diego) selected the next round of startup companies for its genomics accelerator. This is the second, six-month cycle for the Illumina Accelerator, which seeks to aid entrepreneurs...
Laboratory Data and Interoperability to be Focus of FDA Workshop
By Kelly A. Briganti, Editorial Director, G2 Intelligence Recognizing that laboratory tests "influence between 70 to 80 percent of clinical decisions," the Food and Drug Administration, Centers for Disease Control and Prevention (CDC) and the National Library of...